← Back to Search

Proactive CRC Screening for Colorectal Cancer

N/A

Waitlist Available

Led By Aasma Shaukat

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to month 6

Awards & highlights

Study Summary

This trial will study if a program to encourage colorectal cancer screening leads to more people getting tested.

Who is the study for?

This trial is for patients at Flatbush Family Health Center who are due or overdue for colorectal cancer (CRC) screening, aged between 45 and 75. It's not open to those already up-to-date with CRC screening, have a history of CRC, inflammatory bowel disease, colorectal polyps, or lack contact information.Check my eligibility

What is being tested?

The study compares the effectiveness of a proactive CRC screening outreach program against usual care practices in increasing cancer screening rates among eligible patients at the health center.See study design

What are the potential side effects?

Since this trial focuses on the process of getting screened rather than a medical treatment, there aren't direct side effects like you'd expect from drugs. However, participants may experience inconvenience or anxiety related to undergoing screenings.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants who Complete Initial FIT at 6 Months

Number of Participants who Completed Colonoscopy at 6 Months

Secondary outcome measures

Number of Participants with Positive FIT Test who Complete Colonoscopy at 6 Months

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Proactive Screening OutreachExperimental Treatment1 Intervention

Participants will receive a letter from their clinic explaining CRC screening options (fecal immunochemical test (FIT) vs colonoscopy) including a FIT kit with completion and return instructions. The letter will also include information for navigation to a screening colonoscopy instead of FIT testing, if deemed to be the participant's preference. Approximately 10-14 days after mailing the FIT kit, participants who have not completed screening will receive a telephone call (with voice message left) and text message, querying whether the FIT kit was received and reminding the participant to complete the test or request a new kit, if needed. If the FIT kit has not been submitted after about two weeks from the reminder call/text message, the study team will mail a final letter to the participant on behalf of the clinic, reminding them to complete and return the FIT kit.

Group II: Usual CareActive Control1 Intervention

Individuals in the usual care group will not be approached or notified of their enrollment in the study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Proactive CRC Screening Outreach

2023

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,498 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,341 Total Patients Enrolled

Aasma ShaukatPrincipal InvestigatorNYU Langone Health

1 Previous Clinical Trials

3,000 Total Patients Enrolled

Media Library

Proactive CRC Screening Outreach Clinical Trial Eligibility Overview. Trial Name: NCT05646355 — N/A

Colorectal Cancer Research Study Groups: Proactive Screening Outreach, Usual Care

Colorectal Cancer Clinical Trial 2023: Proactive CRC Screening Outreach Highlights & Side Effects. Trial Name: NCT05646355 — N/A

Proactive CRC Screening Outreach 2023 Treatment Timeline for Medical Study. Trial Name: NCT05646355 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an eligibility criterion to join this clinical trial?

"This clinical study is recruiting 100 participants between the ages of 45 and 75 who have been medically diagnosed with colorectal carcinoma."

Answered by AI

Does this trial accept participants of advanced age?

"Per the trial's requirements, eligible participants must be between 45 and 75 years of age. Conversely, 37 trials are open to patients younger than 18 while 1061 cater to those who are over 65."

Answered by AI

Are there vacancies available for participants in this medical trial?

"Data hosted on clinicaltrials.gov attests that this medical trial, first published on January 1st 2023, is not presently accepting new patients. Although the study is inactive at present, there are 1075 other experiments actively seeking to enrol participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Flatbush FHC Proactive Colorectal Cancer Screening and Navigation

2023. "Flatbush FHC Proactive Colorectal Cancer Screening and Navigation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05646355.